Avandia

GlaxoSmithKline Plc (GSK) will reveal detailed results today on an experimental treatment for diabetes thats part of the reason for a $2.6 billion hostile takeover bid for Human Genome Sciences Inc. (HGSI), its partner on the drug. Glaxo will present data from two of eight late-stage studies, dubbed Harmony 6 and Harmony 7, of the once-weekly drug albiglutide ahead of the American Diabetes Association...  

GlaxoSmithKline Plc (GSK) may find its next acquisition target where the U.K. drugmaker found the last two: among more than a dozen companies it collaborates with to develop new treatments. Glaxo has stakes in more than 10 publicly-traded companies, including DiaDexus Inc. (DDXS), which develops diagnostics for detecting heart attack and stroke risk, according to data compiled by Bloomberg. The London...  

05/22 DJ GlaxoSmithKline Buys Back 1.8 Million Shares For Treasury 05/22 DJ GlaxoSmithKline Buys Back 1.8 Million Shares For Treasury 05/22 DJ Roche Drugs To Be Key Focus At Upcoming US Cancer Meeting ASCO 05/22 DJ Roche Drugs To Be Key Focus At Upcoming ...  

(RTTNews) - GlaxoSmithKline plc (GSK: News ,GSK.L: News ) Wednesday amended the conditions of its unsolicited tender offer to acquire Human Genome Sciences (HGSI: News ) for $13.00 per share. The move, the British drug maker said, is in response to a ...  

Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline entered into an agreement Monday to co-promote Testim, Auxilium's testosterone replacement therapy product used in adult males. Under the terms of the agreement, Auxilium (NASDAQ:AUXL) of Malvern, Pa., granted GSK the exclusive right to co-promote Testim in the United States through Sept.30, 2015. Auxilium and GSK (NYSE:GSK) have agreed on an undisclosed baseline revenue forecast for Testim...  

PHILADELPHIA, May 21, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline plc (LSE: GSK), announced today that they have entered into an agreement for the co-promotion of Testim 1% (testosterone gel), which is indicated for testosterone replacement therapy in adult males for conditions...  

GlaxoSmithKline said Tuesday that it will acquire the remaining shares that it does not already own in proteomics technologies company Cellzome for $99 million. Cellzome, a privately owned company with laboratories in Cambridge, UK, and Heidelberg, Germany, will become part of GSK’s R organization. GSK (NYSE: GSK) already has a 19.98 percent equity interest in Cellzome. Cellzome shareholders hope to use the acquisition to create a spin-off...  

GlaxoSmithKline (NYSE: GSK) is increasing its ownership in San Francisco-based Theravance Inc. (Nasdaq: THRX). Following approval Tuesday by Theravance stockholders, GSK’s previously announced acquisition of 10 million shares of Theravance is now complete – meaning GSK owns 25.8 million shares of Theravance common stock. That’s 26.7 percent of the total outstanding capital stock of Theravance. GSK and Theravance long have been collaborators...  

GlaxoSmithKline plc (GSK) recently announced that it has entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for £61 million (US$99M) in cash. Cellzome, a privately owned company with laboratories in Cambridge, UK, and Heidelberg, Germany, will become part of GSK’s R&D organisation.  

LONDON and SOUTH SAN FRANCISCO, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc ("GSK") (LSE:GSK) and Theravance, Inc. ("Theravance") (Nasdaq:THRX) announced today that following approval by Theravance, Inc.'s stockholders at their Annual Meeting held on 15 May 2012, and expiration of applicable waiting periods under the US Hart-Scott-Rodino Antitrust Improvements Act of 1976, GSK's acquisition...  

Job Title: Bottling Engineer Reference: 140512-5Location: GMS Agbara, Ogun State,NigeriaReporting To (Job Title): Head of EngineeringOrganisation: GlaxoSmithKline – GSK NigeriaJob Purpose/Scope:   To ensure the implementation of maintenance activities (planned  

Job Title: Account ManagerReference: 29-11-11:2Location: Lafia / MakurdiReporting To (Job Title): Territory ManagerOrganisation: GlaxoSmithKline – GSK NigeriaJob Purpose/Scope: To manage a Partner or a number of Partner Accounts in a given territory to achieve GSK Revenue and Customer network objectives.Key responsibilities include:•   Achieve P...  

Indias top drug regulatory agency violated laws and colluded with pharmaceutical companies to approve medicines without clinical trials, a parliamentary panel said in a report. The Central Drugs Standard Control Organization which oversees clinical trials and Indias 10,000 drugmakers, approved medicines from companies including Novartis AG (NOVN), GlaxoSmithKline Plc (GSK) and Mumbai-based Cipla...  

MALVERN, Pa. (AP) -- Drug developer Auxilium Pharmaceuticals Inc. improved its outlook for 2012 because of plans to start co-promoting its testosterone gel Testim in the U.S. this summer with British pharmaceutical giant GlaxoSmithKline plc.  

GlaxoSmithKline PLC has made an offer to take over U.S. drug maker Human Genome Sciences Inc. which values the company at nearly $2.6 billion. GlaxoSmithKline, which has profit-sharing agreements with HGS on three drugs but a minimal shareholding, said Wednesday it is offering $13 cash per share for the company. A private offer last month by GSK at the same price was rejected by HGS management ...